Log in

InspireMD Stock Forecast, Price & News

-0.01 (-2.89 %)
(As of 09/22/2020 12:00 AM ET)
Today's Range
Now: $0.34
50-Day Range N/A
52-Week Range
Now: $0.34
Volume613,784 shs
Average Volume1.99 million shs
Market Capitalization$11.19 million
P/E RatioN/A
Dividend YieldN/A
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.
Read More
InspireMD logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.22 out of 5 stars

Industry, Sector and Symbol

Industry Medical Appliances & Equipment
Previous SymbolNASDAQ:NSPR



Sales & Book Value

Annual SalesN/A



Market Cap$11.19 million
Next Earnings Date11/10/2020 (Estimated)
OptionableNot Optionable
-0.01 (-2.89 %)
(As of 09/22/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NSPR News and Ratings via Email

Sign-up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

InspireMD (NYSEAMERICAN:NSPR) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of InspireMD?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InspireMD in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for InspireMD

When is InspireMD's next earnings date?

InspireMD is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for InspireMD

How were InspireMD's earnings last quarter?

InspireMD Inc (NYSEAMERICAN:NSPR) issued its earnings results on Wednesday, August, 5th. The medical equipment provider reported ($0.20) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.35) by $0.15. The medical equipment provider had revenue of $0.31 million for the quarter, compared to analysts' expectations of $0.20 million.
View InspireMD's earnings history

When did InspireMD's stock split? How did InspireMD's stock split work?

InspireMD shares reverse split on Monday, April 1st 2019. The 1-50 reverse split was announced on Tuesday, March 26th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, March 29th 2019. An investor that had 100 shares of InspireMD stock prior to the reverse split would have 2 shares after the split.

What price target have analysts set for NSPR?

1 analysts have issued 1-year price objectives for InspireMD's stock. Their forecasts range from $2.00 to $2.00. On average, they expect InspireMD's stock price to reach $2.00 in the next twelve months. This suggests a possible upside of 496.1% from the stock's current price.
View analysts' price targets for InspireMD

Are investors shorting InspireMD?

InspireMD saw a increase in short interest in August. As of August 31st, there was short interest totaling 246,100 shares, an increase of 18.7% from the August 15th total of 207,300 shares. Based on an average trading volume of 3,680,000 shares, the short-interest ratio is presently 0.1 days.
View InspireMD's Short Interest

Who are some of InspireMD's key competitors?

What other stocks do shareholders of InspireMD own?

Based on aggregate information from My MarketBeat watchlists, some companies that other InspireMD investors own include Biocept (BIOC), Palatin Technologies (PTN), TransEnterix (TRXC), Catalyst Pharmaceuticals (CPRX), Inovio Pharmaceuticals (INO), Curis (CRIS), Ibio (IBIO), Inpixon (INPX), Novavax (NVAX) and Rewalk Robotics (RWLK).

Who are InspireMD's key executives?

InspireMD's management team includes the following people:
  • Dr. James J. Barry, Pres, CEO & Director (Age 60)
  • Mr. Craig Shore, CFO, Chief Admin. Officer, Sec. & Treasurer (Age 58)
  • Mr. Agustin V. Gago, Exec. VP & Chief Commercial Officer (Age 59)
  • Mr. Roei Samuri, VP of Operations
  • Dr. Sol J. Barer, Special Advisor to the Board (Age 72)

What is InspireMD's stock symbol?

InspireMD trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NSPR."

Who are InspireMD's major shareholders?

InspireMD's stock is owned by many different retail and institutional investors. Top institutional shareholders include Wedbush Securities Inc. (2.78%). Company insiders that own InspireMD stock include Paul Stuka and Thomas J Kester.
View institutional ownership trends for InspireMD

Which major investors are buying InspireMD stock?

NSPR stock was purchased by a variety of institutional investors in the last quarter, including Wedbush Securities Inc..
View insider buying and selling activity for InspireMD

How do I buy shares of InspireMD?

Shares of NSPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is InspireMD's stock price today?

One share of NSPR stock can currently be purchased for approximately $0.34.

How big of a company is InspireMD?

InspireMD has a market capitalization of $11.19 million. InspireMD employs 43 workers across the globe.

What is InspireMD's official website?

The official website for InspireMD is www.inspiremd.com.

How can I contact InspireMD?

InspireMD's mailing address is 4 Menorat Hamaor St., TEL AVIV-YAFO, MA 6744832, Israel. The medical equipment provider can be reached via phone at +1-857-4536553.

This page was last updated on 9/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.